High-dimensional immune-system analysis for precision medicine.
| Date | Round | Amount |
|---|---|---|
| Mar 2024 | Funding round Surge, a Paris immune-system-analysis biotech, raised EUR7.5M led by Eurazeo. | $8.1M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.